Pivotal Life Sciences

Pivotal Life Sciences is an investment platform that specializes in providing capital to innovative companies developing therapeutic products and technologies to address major unmet medical needs. The name “Pivotal” synthesizes their investment approach with the role they strive to play in the companies they invest in. Their strategy is to invest in companies of all stages, with a primary focus on “high impact” therapeutics – solutions that address growing unmet medical needs and with near-curative or otherwise transformative disease management potential. They operate primarily in the life sciences sector, including therapeutics, devices, and medtech globally. Pivotal Life Sciences is backed by the Nan Fung Group, a large Hong Kong-based conglomerate with diversified business interests and investments. Pivotal Life Sciences was founded in 2017 and has been actively supporting talented entrepreneurs who build category-defining tech-enabled companies across the globe. They provide smart capital and operational expertise to the startups they support. Their team, a mix of founders and investors, understands the highs and lows of building companies in the life sciences field. They offer day-to-day support, including business development and recruitment, along with access to their network. Pivotal Life Sciences continues to serve as an ideal ally for startups in emerging markets. Their community of investors collaborates with them to deliver outsized financial returns while making a positive impact on healthcare. These investors include entrepreneurs, family offices, executives, and finance professionals based in Europe or Africa.